UnknownPhase 2NCT05403229
The Role of Migraine Prophylaxis Agent Topiramate in Treating Patients With Sudden Sensorineural Hearing Loss
Studying Sudden sensorineural hearing loss
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Chang Gung Memorial Hospital
- Principal Investigator
- BANG-YAN ZHANG, MD.New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation)
- Intervention
- Topiramate(drug)
- Enrollment
- 140 target
- Eligibility
- 20 years · All sexes
- Timeline
- 2022 – 2025
Study locations (1)
- New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05403229 on ClinicalTrials.govOther trials for Sudden sensorineural hearing loss
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONEARLY PHASE1NCT07472023Regenerative Medicine and Stem Cell-Based Interventions for Inner Ear Trauma, Tinnitus, and Sensorineural Hearing LossTruway Health, Inc.
- ACTIVE NOT RECRUITINGNANCT07045883Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing LossZhongshan Hospital Xiamen University
- RECRUITINGPHASE4NCT06968507Comparison of the Effectiveness of Oral and Intratympanic Corticosteroid Treatments in Patients Diagnosed With Sudden Sensorineural Hearing LossDr. Lutfi Kirdar Kartal Training and Research Hospital
- ENROLLING BY INVITATIONNCT06355102The Development of Tinnitus in Patients With SSNHL: Insights From fMRI and MetabolomicsThe First Affiliated Hospital with Nanjing Medical University
- RECRUITINGPHASE1, PHASE2NCT06249919A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL PatientsNeuracle Science Co., LTD.
- RECRUITINGPHASE4NCT04826237Oral Statins and Protection From Hearing LossNorthwestern University
- ACTIVE NOT RECRUITINGPHASE2NCT05776459Efficacy and Safety of AC102 Compared to Steroids in Adults With Idiopathic Sudden Sensorineural Hearing Loss (ISSNHL)AudioCure Pharma GmbH
- RECRUITINGNCT05474963Sudden Sensorineural Hearing Loss in Wonju Severance Christian HospitalWonju Severance Christian Hospital